Filter Results

Clinical Studies


  • Development of a de novo Clinical Outcomes Assessment (COA) for Chronic Intestinal Pseudo Obstruction (CIPO) Rochester, Minn.

    The purpose of this of this study is to develop a de novo CIPO-specific PRO (chronic intestinal pseudo obstruction) (patient recorded outcomes) that is able to capture change in core CIPO visible signs and symptoms across all etiologies and severity levels, and is fit-for-purpose for use as a primary endpoint in a clinical trial setting.

  • Mucosal and Microbiota Changes During Acute Campylobacteriosis Rochester, Minn.

    Gastrointestinal (GI) infection with Campylobacter causes inflammation in the bowel and can change bacteria in the gut. Certain individuals with Campylobacter infection are also known to develop chronic bowel problems such as Irritable Bowel Syndrome (IBS). The researchers are doing this study to understand if changes in gut bacteria and gut mucosal lining during an acute infection can help identify individuals who might be at risk for developing problems in the future.

Contact Us for the Latest Status

Closed for Enrollment